{"transactions":[{"id":730156,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:52:26.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":59000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":59000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":59000},"source":{"system":"sec-edgar","filing":"0001610717-26-000279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071726000279/form4.xml","form_type":"4"}},{"id":1111131,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:18:47.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2026 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-25-000214","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071725000214/form4.xml","form_type":"4"}},{"id":1510699,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-17T21:36:18.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2025 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":38000,"derivative":{"exercise_price":1.96,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001610717-24-000248","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071724000248/form4.xml","form_type":"4"}},{"id":1851577,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T21:51:46.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.57,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-23-000181","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000161071723000181/form4.xml","form_type":"4"}},{"id":2227053,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-17T20:07:51.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.72,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-22-013075","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922013075/doc1.xml","form_type":"4"}},{"id":2647123,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T21:43:37.000Z","date":"2021-07-01","kind":"disposition_to_issuer","acquired":false,"shares":7127,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (as it may be amended from time to time) (the \"Merger Agreement\"), dated as of February 24, 2021, by and among the Issuer, ICON plc (\"ICON\"), ICON US Holdings Inc. (\"US HoldCo\") and Indigo Merger Sub, Inc., each share of the Issuer's common stock was converted into the right to receive from ICON, 0.4125 of one ordinary share of ICON, and, from US HoldCo, $80.00 in cash, without any interest thereon (collectively, the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each award of restricted stock of the Issuer that is outstanding immediately prior to the effective time of the merger was converted into the right to receive the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-088359","document":"tm2121280-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465921088359/tm2121280-6_4seq1.xml","form_type":"4"}},{"id":2663093,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T22:47:31.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":7.13,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-012371","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921012371/doc1.xml","form_type":"4"}},{"id":2682330,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T20:05:22.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock granted under the PRA Health Sciences, Inc. 2020 Stock Incentive Plan that will vest on June 1, 2022, subject to continued service on such date. Further, the grant shall vest in full upon a change in control as defined under the applicable award agreement."}],"balance_after":7127,"source":{"system":"sec-edgar","filing":"0001104659-21-076362","document":"tm2118302-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465921076362/tm2118302-9_4seq1.xml","form_type":"4"}},{"id":3106476,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-17T21:12:29.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.35,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-012304","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920012304/doc1.xml","form_type":"4"}},{"id":3140361,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T20:57:44.000Z","date":"2020-05-18","kind":"grant","acquired":true,"shares":1324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock that will vest on the first anniversary of the grant date, subject to continued service on such date."}],"balance_after":6877,"source":{"system":"sec-edgar","filing":"0001104659-20-064309","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465920064309/a4.xml","form_type":"4"}},{"id":3480990,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T18:05:54.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2020 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":11.31,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-013826","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919013826/doc1.xml","form_type":"4"}},{"id":3499945,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-05T21:04:05.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":1436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock that will vest on the first anniversary of the grant date, subject to continued service on such date."}],"balance_after":5553,"source":{"system":"sec-edgar","filing":"0001104659-19-034065","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465919034065/a4.xml","form_type":"4"}},{"id":3605947,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:13:56.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":1152,"price":135.41,"value":155992.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":36200,"source":{"system":"sec-edgar","filing":"0001765581-19-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000041/edgardoc.xml","form_type":"4"}},{"id":3605946,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:13:56.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":1348,"price":135.82,"value":183085.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":37352,"source":{"system":"sec-edgar","filing":"0001765581-19-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000041/edgardoc.xml","form_type":"4"}},{"id":3605945,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:13:56.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":1267,"price":135.82,"value":172083.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":38700,"source":{"system":"sec-edgar","filing":"0001765581-19-000041","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000041/edgardoc.xml","form_type":"4"}},{"id":3618445,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-05T00:45:22.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":29286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":29286,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":29286},"source":{"system":"sec-edgar","filing":"0001765581-19-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000029/edgardoc.xml","form_type":"4"}},{"id":3618444,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-03-05T00:45:22.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":714,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":714},"source":{"system":"sec-edgar","filing":"0001765581-19-000029","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000029/edgardoc.xml","form_type":"4"}},{"id":3618443,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-03-05T00:45:22.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":39967,"source":{"system":"sec-edgar","filing":"0001765581-19-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000029/edgardoc.xml","form_type":"4"}},{"id":3628757,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-28T01:38:43.000Z","date":"2019-02-27","kind":"sale","acquired":false,"shares":884,"price":137.91,"value":121912.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27967,"source":{"system":"sec-edgar","filing":"0001765581-19-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000012/edgardoc.xml","form_type":"4"}},{"id":3628756,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-28T01:38:43.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":1034,"price":127.76,"value":132103.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":28851,"source":{"system":"sec-edgar","filing":"0001765581-19-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000012/edgardoc.xml","form_type":"4"}},{"id":3628755,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-28T01:38:43.000Z","date":"2019-02-26","kind":"sale","acquired":false,"shares":1032,"price":125.93,"value":129959.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":29885,"source":{"system":"sec-edgar","filing":"0001765581-19-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000012/edgardoc.xml","form_type":"4"}},{"id":3628754,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-02-28T01:38:43.000Z","date":"2019-02-25","kind":"tax_withholding","acquired":false,"shares":1218,"price":126.25,"value":153772.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018."}],"balance_after":30917,"source":{"system":"sec-edgar","filing":"0001765581-19-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000012/edgardoc.xml","form_type":"4"}},{"id":3751682,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-11-27T21:54:42.000Z","date":"2018-11-23","kind":"sale","acquired":false,"shares":700,"price":150,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":32068,"source":{"system":"sec-edgar","filing":"0001232524-18-000198","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000198/edgardoc.xml","form_type":"4"}},{"id":3788057,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-10-17T20:29:34.000Z","date":"2018-10-15","kind":"sale","acquired":false,"shares":700,"price":158.0828,"value":110657.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $158.0762 to $158.0916. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":32768,"source":{"system":"sec-edgar","filing":"0001232524-18-000180","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000180/edgardoc.xml","form_type":"4"}},{"id":3811449,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-09-19T21:05:42.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":700,"price":162.7,"value":113890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":33468,"source":{"system":"sec-edgar","filing":"0001232524-18-000171","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000171/edgardoc.xml","form_type":"4"}},{"id":3841501,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-08-16T22:57:41.000Z","date":"2018-08-15","kind":"sale","acquired":false,"shares":700,"price":176.05,"value":123235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":34168,"source":{"system":"sec-edgar","filing":"0001232524-18-000165","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000165/edgardoc.xml","form_type":"4"}},{"id":3865116,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-07-18T21:06:36.000Z","date":"2018-07-16","kind":"sale","acquired":false,"shares":700,"price":176.06,"value":123242.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":34868,"source":{"system":"sec-edgar","filing":"0001232524-18-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000121/edgardoc.xml","form_type":"4"}},{"id":3883805,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-25T20:06:31.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":1307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock which will vest fifty percent on each of the first two anniversaries of the grant date, subject to continued service on such dates."}],"balance_after":4117,"source":{"system":"sec-edgar","filing":"0001104659-18-042050","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465918042050/a4.xml","form_type":"4"}},{"id":3888345,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-06-19T20:26:57.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":700,"price":176.99,"value":123893.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":35568,"source":{"system":"sec-edgar","filing":"0001232524-18-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000115/edgardoc.xml","form_type":"4"}},{"id":3892134,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:49:03.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":25.25,"expiration_date":"2028-06-12","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000899243-18-016820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000089924318016820/doc4.xml","form_type":"4"}},{"id":3904891,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-05T22:52:06.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This non-qualified stock option is part of an option award granted on May 3, 2013. The ordinary shares subject to the option award vested over 4 years from the vesting commencement date of April 22, 2013, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of April 22, 2017."}],"balance_after":12192,"derivative":{"exercise_price":58.72,"expiration_date":"2023-05-02","underlying":"Ordinary Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001232524-18-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000109/edgardoc.xml","form_type":"4"}},{"id":3904890,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-06-05T22:52:06.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":5000,"price":170.0424,"value":850212.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $170.0000 to $170.3100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":36268,"source":{"system":"sec-edgar","filing":"0001232524-18-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000109/edgardoc.xml","form_type":"4"}},{"id":3904889,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-06-05T22:52:06.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":5000,"price":58.72,"value":293600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 65 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":41268,"source":{"system":"sec-edgar","filing":"0001232524-18-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000109/edgardoc.xml","form_type":"4"}},{"id":3930508,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-05-16T20:54:20.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":1420,"price":164.64,"value":233788.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":36203,"source":{"system":"sec-edgar","filing":"0001232524-18-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000105/edgardoc.xml","form_type":"4"}},{"id":3930507,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-05-16T20:54:20.000Z","date":"2018-05-14","kind":"tax_withholding","acquired":false,"shares":842,"price":166,"value":139772.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":37623,"source":{"system":"sec-edgar","filing":"0001232524-18-000105","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000105/edgardoc.xml","form_type":"4"}},{"id":3960839,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-04-18T21:09:04.000Z","date":"2018-04-16","kind":"sale","acquired":false,"shares":700,"price":156.01,"value":109207.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":38465,"source":{"system":"sec-edgar","filing":"0001232524-18-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000080/edgardoc.xml","form_type":"4"}},{"id":3989188,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-03-19T20:44:12.000Z","date":"2018-03-15","kind":"sale","acquired":false,"shares":700,"price":151.22,"value":105854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":39165,"source":{"system":"sec-edgar","filing":"0001232524-18-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000072/edgardoc.xml","form_type":"4"}},{"id":4007839,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-03-07T21:10:04.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":352,"price":143.0406,"value":50350.2912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $142.6400 to $143.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":39865,"source":{"system":"sec-edgar","filing":"0001232524-18-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000059/edgardoc.xml","form_type":"4"}},{"id":4007838,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-03-07T21:10:04.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":800,"price":142.06,"value":113648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $141.4500 to $142.4200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":40217,"source":{"system":"sec-edgar","filing":"0001232524-18-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000059/edgardoc.xml","form_type":"4"}},{"id":4007837,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-03-07T21:10:04.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":1348,"price":143.39,"value":193289.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":41017,"source":{"system":"sec-edgar","filing":"0001232524-18-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000059/edgardoc.xml","form_type":"4"}},{"id":4014385,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-05T21:39:40.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":22790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":22790,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":22790},"source":{"system":"sec-edgar","filing":"0001232524-18-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000050/edgardoc.xml","form_type":"4"}},{"id":4014384,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-05T21:39:40.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":710,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":710},"source":{"system":"sec-edgar","filing":"0001232524-18-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000050/edgardoc.xml","form_type":"4"}},{"id":4014383,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-03-05T21:39:40.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":9400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2018, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":42365,"source":{"system":"sec-edgar","filing":"0001232524-18-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000050/edgardoc.xml","form_type":"4"}},{"id":4026786,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":700,"price":150,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":32965,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026785,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":200,"price":149.015,"value":29803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.6200 to $149.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":33665,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026784,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":119,"price":147.5561,"value":17559.1759,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.2200 to $147.6200. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":33865,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026783,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-28","kind":"sale","acquired":false,"shares":200,"price":145.245,"value":29049.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.0500 to $145.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":33984,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026782,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":606,"price":143.8,"value":87142.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":34184,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026781,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":300,"price":147.2967,"value":44189.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $147.0600 to $147.4400. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":34790,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026780,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":600,"price":145.8333,"value":87499.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $145.4300 to $146.2700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":35090,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026779,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":1016,"price":144.961,"value":147280.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.3100 to $145.2600. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":35690,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4026778,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:57:18.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":2253,"price":147.44,"value":332182.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":36706,"source":{"system":"sec-edgar","filing":"0001232524-18-000032","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000032/edgardoc.xml","form_type":"4"}},{"id":4095959,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2018-01-18T22:05:41.000Z","date":"2018-01-16","kind":"sale","acquired":false,"shares":700,"price":152.16,"value":106512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62 ordinary shares acquired on May 31, 2017 and 64 ordinary shares acquired on November 30, 2017 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":38959,"source":{"system":"sec-edgar","filing":"0001601583-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160158318000002/edgardoc.xml","form_type":"4"}},{"id":4157567,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T21:05:23.000Z","date":"2017-11-16","kind":"sale","acquired":false,"shares":5115,"price":79.9,"value":408688.5,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $79.85 to $79.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-17-069448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465917069448/a4.xml","form_type":"4"}},{"id":4157566,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T21:05:23.000Z","date":"2017-11-14","kind":"gift","acquired":true,"shares":5115,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":5115,"source":{"system":"sec-edgar","filing":"0001104659-17-069448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465917069448/a4.xml","form_type":"4"}},{"id":4157565,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T21:05:23.000Z","date":"2017-11-14","kind":"gift","acquired":false,"shares":5115,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2810,"source":{"system":"sec-edgar","filing":"0001104659-17-069448","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465917069448/a4.xml","form_type":"4"}},{"id":4256947,"issuer":{"id":15912,"kind":"organization","name":"PRA Health Sciences, Inc.","symbol":"PRAH"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-14T20:05:35.000Z","date":"2017-07-12","kind":"grant","acquired":true,"shares":1318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock which will vest fifty percent on each of the first two anniversaries of the grant date, subject to continued service on such dates."}],"balance_after":7925,"source":{"system":"sec-edgar","filing":"0001104659-17-045047","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601583/000110465917045047/a4.xml","form_type":"4"}},{"id":4274256,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T18:00:17.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on June 20, 2018 subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":14000,"derivative":{"exercise_price":13.78,"expiration_date":"2027-06-19","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001140361-17-025792","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117025792/doc1.xml","form_type":"4"}},{"id":4317982,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-05-16T22:29:27.000Z","date":"2017-05-12","kind":"tax_withholding","acquired":false,"shares":815,"price":153.79,"value":125338.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":39533,"source":{"system":"sec-edgar","filing":"0001232524-17-000117","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000117/edgardoc.xml","form_type":"4"}},{"id":4331526,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-05-05T20:50:02.000Z","date":"2017-05-03","kind":"tax_withholding","acquired":false,"shares":1565,"price":158.38,"value":247864.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":40348,"source":{"system":"sec-edgar","filing":"0001601583-17-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160158317000003/edgardoc.xml","form_type":"4"}},{"id":4400072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-07T00:00:12.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":24266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":24266,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":24266},"source":{"system":"sec-edgar","filing":"0001232524-17-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000064/edgardoc.xml","form_type":"4"}},{"id":4400071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-07T00:00:12.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":734,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":734},"source":{"system":"sec-edgar","filing":"0001232524-17-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000064/edgardoc.xml","form_type":"4"}},{"id":4400070,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-03-07T00:00:12.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":41913,"source":{"system":"sec-edgar","filing":"0001232524-17-000064","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000064/edgardoc.xml","form_type":"4"}},{"id":4413624,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":36262,"kind":"person","name":"Young Matthew P.","position":1,"cik":"0001601583","reported_name":"Young Matthew P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2017-03-01T22:18:06.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":1994,"price":136.97,"value":273118.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 39 ordinary shares acquired on May 31, 2016 and 59 ordinary shares acquired on November 30, 2016 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":31913,"source":{"system":"sec-edgar","filing":"0001232524-17-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000039/edgardoc.xml","form_type":"4"}}]}